KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Interest Expenses (2018 - 2025)

Castle Biosciences' Interest Expenses history spans 7 years, with the latest figure at $24000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses fell 83.67% year-over-year to $24000.0; the TTM value through Dec 2025 reached $86000.0, down 85.1%, while the annual FY2025 figure was $86000.0, 85.1% down from the prior year.
  • Interest Expenses for Q4 2025 was $24000.0 at Castle Biosciences, roughly flat from $24000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $217000.0 in Q2 2024 and bottomed at $1000.0 in Q4 2021.
  • The 5-year median for Interest Expenses is $6000.0 (2022), against an average of $40705.9.
  • The largest annual shift saw Interest Expenses crashed 99.75% in 2021 before it soared 9950.0% in 2024.
  • A 5-year view of Interest Expenses shows it stood at $1000.0 in 2021, then soared by 300.0% to $4000.0 in 2022, then crashed by 50.0% to $2000.0 in 2023, then skyrocketed by 7250.0% to $147000.0 in 2024, then crashed by 83.67% to $24000.0 in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Interest Expenses are $24000.0 (Q4 2025), $24000.0 (Q3 2025), and $21000.0 (Q2 2025).